Zastosowanie wemurafenibu w opornej na leczenie histiocytozie z komórek langerhansa Cover

.blurhash-client-img { display: none !important; }

Zastosowanie wemurafenibu w opornej na leczenie histiocytozie z komórek langerhansa

Journal of Mother and Child

Volume 22 (2018): Issue 4 (December 2018)

By: Anna Raciborska, Zofia Małas and Andrzej Tysarowski

Open Access

|Jan 2019

References

Emile JF, Abla Q, Fraitag S, Hornes A, Haroches J, Donandieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Hentler JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vaddallo R, Weiss LM for the Histiocyte Society. Revised classification ofhistiocytoses and neoplasms of the macrophagr-dendritic cell lineages. Blood 2016 Jun 2;127(22):2672-2681.
Search in Google Scholar Back to article
Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, Egeler RM, Janka G, Micic D, Rodriguez-Galindo C, Van Gool S, Visser J, Weitzman S, Donadieu J; Euro Histio Network. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013 Feb;60(2):175-178.
Search in Google Scholar Back to article
Adam E, Jubran R, Weitzman S. Epidemiology and clinical manifestation of Langerhans cell histiocytosis in children. W: Histiocytic disorders. Abla O, Janka G (red.) 1^st ed. Springer, 2018.
Search in Google Scholar Back to article
Raciborska A, Rogowska E, Słowińska M. Pacjent z Histiocytozą z komórek Langerhansa. Co ważnego dla Pediatry. Pediatr Dyplom. 2018,3:75-84.
Search in Google Scholar Back to article
Heisig A, Sörensen J, Zimmermann SY, Schöning S, Schwabe D, Kvasnicka HM, Schwentner R, Hutter C, Lehrnbecher T. Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature. Oncotarget. 2018 Apr 24;9(31):22236-22240.
Search in Google Scholar Back to article
Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010 Sep 16;116(11):1919-1923.
Search in Google Scholar Back to article
Tran G, Huynh TN, Paller AS. Langerhans cell histiocytosia: a neoplastic disorder driven by Ras-ERK pathway mutations. J Am Acad Dermatol. 2018 Mar;78(3):579-590.
Search in Google Scholar Back to article
Rollins BJ. Biology and genomics of LCH and related disorders. W: Histiocytic disorders. Abla O, Janka G (red.) 1^st ed. Springer, 2018.
Search in Google Scholar Back to article
Rizzo FM, Cives M, Simone V, Silvestris F. New insights into the molecular pathogenesis of langerhans cell histiocytosis. Oncologist. 2014 Feb;19(2):151-163.
Search in Google Scholar Back to article
Hutter C, Minkov M. Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies. Immunotargets Ther. 2016 Oct 12;5:81-91.
Search in Google Scholar Back to article
Haroche J, Cohen-Aubart F, Emile JF, Donadieu J, Amoura Z. Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis. J Am Acad Dermatol. 2015 Jul; 73(1):e29-30.
Search in Google Scholar Back to article
Héritier S, Jehanne M, Leverger G, Emile JF, Alvarez JC, Haroche J, Donadieu J. Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis. JAMA Oncol. 2015 Sep; 1(6):836-838.
Search in Google Scholar Back to article

DOI: https://doi.org/10.34763/devperiodmed.20182204.376378 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488

Journal RSS Feed

Language: English

Page range: 376 - 378

Submitted on: Nov 6, 2018

Accepted on: Nov 20, 2018

Published on: Jan 14, 2019

Published by: Institute of Mother and Child

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

histiocytoza z komórek Langerhansa,

inhibitory BRAF,

Related subjects:

Clinical medicine,

Pediatrics and juvenile medicine,

Paediatric haematology and oncology,

© 2019 Anna Raciborska, Zofia Małas, Andrzej Tysarowski, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 22 (2018): Issue 4 (December 2018)Next article